Yahoo Web Search

Search results

  1. People also ask

  2. Aug 23, 2021 · Post. For Immediate Release: August 23, 2021. Español. Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech...

  3. Sep 11, 2023 · On September 11, 2023, the Food and Drug Administration amended the emergency use authorization (EUA) of Pfizer-BioNTech COVID-19 Vaccine to include the 2023-2024 formula. The...

  4. Sep 11, 2023 · Approval of Comirnaty (COVID-19 Vaccine, mRNA) to include the 2023-2024 formula, and a change to a single dose for individuals 12 years of age and older. Comirnaty was previously approved...

  5. Jun 3, 2022 · This vaccine resource provides key vaccine-specific information for the Pfizer-BioNTech COVID-19 Vaccine Comirnaty ®, a messenger RNA (mRNA) based vaccine against coronavirus disease (COVID-19). This document has been updated in English: version 03 June 2022.

  6. COMIRNATY (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine made by Pfizer for BioNTech that is indicated for active immunization to prevent COVID-19 in individuals 12 years of age and older. It is approved for use as a 2-dose primary series for the prevention of COVID-19 in individuals 12 years of age and older.

  7. Oct 20, 2021 · Comirnaty is the brand name for Pfizer's coronavirus vaccine. The FDA approved the shot in late August for Americans ages 16 and older. But posts claiming Comirnaty is not yet available...

  8. Sep 11, 2023 · You should NOT receive COMIRNATY ® (COVID-19 Vaccine, mRNA) if you have had a severe allergic reaction to any ingredient of COMIRNATY or a previous dose of a Pfizer-BioNTech COVID-19 vaccine. There is a remote chance that COMIRNATY could cause a severe allergic reaction.

  1. People also search for